{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:00:06Z","timestamp":1787806806349,"version":"build-2784847793"},"reference-count":39,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"commercial, or not-for-profit"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1080\/14712598.2021.2002296","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T15:59:11Z","timestamp":1635955151000},"page":"197-202","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9950-2489","authenticated-orcid":false,"given":"Fatma G\u00fcl","family":"Demirkan","sequence":"first","affiliation":[{"name":"Department of Pediatric Rheumatology, Istanbul University, Istanbul School of Medicine, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8197-6077","authenticated-orcid":false,"given":"Kadir","family":"Ulu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, University of Health Sciences, \u00dcmraniye Research and Training Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0466-0228","authenticated-orcid":false,"given":"K\u00fcbra","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Istanbul Medeniyet University, School of Medicine, Goztepe Research and Training Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3232-0055","authenticated-orcid":false,"given":"\u015eerife G\u00fcl","family":"Karada\u011f","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, University of Health Sciences, Bak\u0131rk\u00f6y Dr. SadiKonuk Training and Research Hospital, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5602-4595","authenticated-orcid":false,"given":"Semanur","family":"\u00d6zdel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, University of Health Sciences, Dr. Sami Ulus Obstetrics and Gynecology, Pediatric Health and Disease Training and Research Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9186-3068","authenticated-orcid":false,"given":"Hafize Emine","family":"S\u00f6nmez","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Kocaeli University, Kocaeli School of Medicine, Kocaeli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-2480","authenticated-orcid":false,"given":"Figen","family":"\u00c7akmak","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Istanbul University, Istanbul School of Medicine, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9801-925X","authenticated-orcid":false,"given":"Ferhat","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, University of Health Sciences, \u00dcmraniye Research and Training Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-5644","authenticated-orcid":false,"given":"Bet\u00fcl","family":"S\u00f6zeri","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, University of Health Sciences, \u00dcmraniye Research and Training Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-7387","authenticated-orcid":false,"given":"Nuray","family":"Aktay Ayaz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Istanbul University, Istanbul School of Medicine, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15756"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S12494"},{"issue":"2","key":"e_1_3_7_4_1","first-page":"118","article-title":"The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis","volume":"7","author":"Cakan M","year":"2020","unstructured":"Cakan M, Ayaz NA, Karadag SG, et al. The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis. North Clin Istanb. 2020;7(2):118\u2013123.","journal-title":"North Clin Istanb"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12294"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0769-6"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.4155\/ppa-2017-0012"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.02.003"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00507-1"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00355-4"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab572"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/r4gnxm"},{"issue":"2","key":"e_1_3_7_13_1","first-page":"200","article-title":"Time to collaborate: objectives, design, and methodology of PeRA-research group","volume":"8","author":"Sozeri B","year":"2021","unstructured":"Sozeri B, Emine Sonmez H, Demir F, et al. Time to collaborate: objectives, design, and methodology of PeRA-research group. North Clin Istanb. 2021;8(2):200\u2013202.","journal-title":"North Clin Istanb"},{"key":"e_1_3_7_14_1","unstructured":"T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu. \u0130la\u00e7 G\u00fcvenlik \u0130zlem Formuyla Kullan\u0131lan \u0130la\u00e7lar Listesi 2021. [cited 2021 Sep 10]. Available from: https:\/\/www.titck.gov.tr\/dinamikmodul\/110."},{"issue":"2","key":"e_1_3_7_15_1","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, edmonton, 2001","volume":"31","author":"Petty RE","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, edmonton, 2001. J Rheumatol. 2004;31(2):390\u2013392.","journal-title":"J Rheumatol"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180168"},{"issue":"2","key":"e_1_3_7_17_1","first-page":"367","article-title":"The evaluation of uveitis in juvenile idiopathic arthritis (JIA) patients: are current ophthalmologic screening guidelines adequate?","volume":"26","author":"Reininga JK","year":"2008","unstructured":"Reininga JK, Los LI, Wulffraat NM, et al. The evaluation of uveitis in juvenile idiopathic arthritis (JIA) patients: are current ophthalmologic screening guidelines adequate? Clin Exp Rheumatol. 2008;26(2):367\u2013372.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34373"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0085-5"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24516"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22411"},{"key":"e_1_3_7_22_1","unstructured":"Information for Healthcare Professionals. Cimzia (certolizumab pegol) Enbrel (etanercept) Humira (Adalimumab) and Remicade (infliximab). [cited 2021 Feb 25]. Available from: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/information-tumor-necrosis-factor-tnf-blockers-marketed-remicade-enbrel-humira-cimzia-and-simponi"},{"key":"e_1_3_7_23_1","unstructured":"European Medicines Agency. Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues. EMEA\/CHMP\/BMWP\/42832\/2005 Rev1. 2014 . [cited 2021 Nov 12]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-similar-biological-medicinal-products-containing-biotechnology-derived-proteins-active_en-2.pdf."},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203090"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108447"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210459"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.11.002"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11067"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-019-0166-2"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.08.003"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_120_19"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.014"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11325"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1817501"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.682327"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132934"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1763300"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.10.952"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01372"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.30.1.76"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2021.2002296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T05:14:46Z","timestamp":1721625286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2021.2002296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1080\/14712598.2021.2002296"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2021.2002296","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}